Thrive Wealth Management LLC Has $302,000 Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Thrive Wealth Management LLC lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 7.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,286 shares of the medical device company’s stock after selling 270 shares during the period. Thrive Wealth Management LLC’s holdings in Cooper Companies were worth $302,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Ashton Thomas Securities LLC bought a new position in Cooper Companies during the third quarter worth $25,000. Covestor Ltd raised its stake in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after buying an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. raised its stake in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after buying an additional 275 shares during the last quarter. Friedenthal Financial bought a new position in Cooper Companies during the third quarter worth $50,000. Finally, Cromwell Holdings LLC bought a new stake in Cooper Companies in the third quarter valued at $52,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on COO shares. Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup decreased their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Up 1.3 %

COO opened at $93.27 on Monday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market cap of $18.61 billion, a price-to-earnings ratio of 47.83, a PEG ratio of 2.29 and a beta of 0.99. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company’s 50-day moving average price is $96.54 and its two-hundred day moving average price is $99.08.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Cooper Companies’s revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.